Literature DB >> 23468107

Cytokines in the balance of protection and pathology during mycobacterial infections.

Egídio Torrado1, Andrea M Cooper.   

Abstract

The outcome of natural infections with pathogenic mycobacteria can range from early asymptomatic clearance through latent infection to clinical disease. Different host and pathogen-specific factors have been implicated in determining the outcome of these infections; however, it is clear that the interaction of mycobacteria with the innate and acquired components of the immune system plays a central role. Specifically, the recognition of mycobacterial components by innate immune cells through different pathogen recognition receptors (PPRs) induces a cytokine response that can promote early control of the infection. In fact, in the majority of individuals that come into contact with mycobacteria, this response is enough to control the infection. Among PRRs, Toll-like receptors (TLRs), Nucleotide Oligomerization Domain (NOD)-like receptors, and C-type lectins have all been implicated in recognition of mycobacteria and in the initiation of the cytokine response. Defining the mechanisms by which distinct mycobacterial components and their receptors stimulate the immune response is an area of intense research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23468107      PMCID: PMC3773506          DOI: 10.1007/978-1-4614-6111-1_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  86 in total

Review 1.  Th17 cells and mucosal host defense.

Authors:  Shean J Aujla; Patricia J Dubin; Jay K Kolls
Journal:  Semin Immunol       Date:  2007-11-28       Impact factor: 11.130

2.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes.

Authors:  William W Reiley; Mark D Calayag; Susan T Wittmer; Jennifer L Huntington; John E Pearl; Jeffrey J Fountain; Cynthia A Martino; Alan D Roberts; Andrea M Cooper; Gary M Winslow; David L Woodland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

3.  ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection.

Authors:  Ingrid C Koo; Chen Wang; Sridharan Raghavan; J Hiroshi Morisaki; Jeffery S Cox; Eric J Brown
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

4.  Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice.

Authors:  Gillian L Beamer; David K Flaherty; Barnabe D Assogba; Paul Stromberg; Mercedes Gonzalez-Juarrero; Rene de Waal Malefyt; Bridget Vesosky; Joanne Turner
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

5.  Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

Authors:  Karim C El Kasmi; Joseph E Qualls; John T Pesce; Amber M Smith; Robert W Thompson; Marcela Henao-Tamayo; Randall J Basaraba; Till König; Ulrike Schleicher; Mi-Sun Koo; Gilla Kaplan; Katherine A Fitzgerald; Elaine I Tuomanen; Ian M Orme; Thirumala-Devi Kanneganti; Christian Bogdan; Thomas A Wynn; Peter J Murray
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

6.  IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver.

Authors:  Satoru Hamada; Masayuki Umemura; Takeru Shiono; Kensho Tanaka; Ayano Yahagi; M Dilara Begum; Kiyotetsu Oshiro; Yuko Okamoto; Hisami Watanabe; Kazuyoshi Kawakami; Christina Roark; Willi K Born; Rebecca O'Brien; Koichi Ikuta; Hiromichi Ishikawa; Susumu Nakae; Yoichiro Iwakura; Takao Ohta; Goro Matsuzaki
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 7.  The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

8.  Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Authors:  Thomas J Scriba; Barbara Kalsdorf; Deborah-Ann Abrahams; Fatima Isaacs; Jessica Hofmeister; Gillian Black; Hisham Y Hassan; Robert J Wilkinson; Gerhard Walzl; Sebastian J Gelderbloem; Hassan Mahomed; Gregory D Hussey; Willem A Hanekom
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.

Authors:  Andrea J Wolf; Ludovic Desvignes; Beth Linas; Niaz Banaiee; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Exp Med       Date:  2007-12-24       Impact factor: 14.307

10.  Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection.

Authors:  Alena M Gallegos; Eric G Pamer; Michael S Glickman
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  29 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Authors:  Jong-Seok Kim; Min-Jung Kang; Woo Sik Kim; Seung Jung Han; Hong Min Kim; Ho Won Kim; Kee Woong Kwon; So Jeong Kim; Seung Bin Cha; Seok-Yong Eum; Won-Jung Koh; Sang-Nae Cho; Jong-Hwan Park; Sung Jae Shin
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 3.  Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

Authors:  Ana Esteve-Solé; Ithaisa Sologuren; María Teresa Martínez-Saavedra; Àngela Deyà-Martínez; Carmen Oleaga-Quintas; Rubén Martinez-Barricarte; Andrea Martin-Nalda; Manel Juan; Jean-Laurent Casanova; Carlos Rodriguez-Gallego; Laia Alsina; Jacinta Bustamante
Journal:  Crit Rev Clin Lab Sci       Date:  2018-03-04       Impact factor: 6.250

4.  Heme Oxygenase-1 Regulates Inflammation and Mycobacterial Survival in Human Macrophages during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn R Scharn; Angela C Collins; Vidhya R Nair; Chelsea E Stamm; Denise K Marciano; Edward A Graviss; Michael U Shiloh
Journal:  J Immunol       Date:  2016-04-22       Impact factor: 5.422

5.  Myeloid Sirtuin 2 Expression Does Not Impact Long-Term Mycobacterium tuberculosis Control.

Authors:  Filipa Cardoso; Flávia Castro; Lúcia Moreira-Teixeira; Jeremy Sousa; Egídio Torrado; Ricardo Silvestre; António Gil Castro; Margarida Saraiva; Teresa F Pais
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 6.  Reflections on the immunology of tuberculosis: will we ever unravel the skein?

Authors:  Maurizio de Martino; Luisa Galli; Elena Chiappini
Journal:  BMC Infect Dis       Date:  2014-01-08       Impact factor: 3.090

7.  Characterization of Proinflammatory Responses and Innate Signaling Activation in Macrophages Infected with Mycobacterium scrofulaceum.

Authors:  Ki-Hye Kim; Tae-Sung Kim; Joy G Lee; Jeong-Kyu Park; Miso Yang; Jin-Man Kim; Eun-Kyeong Jo; Jae-Min Yuk
Journal:  Immune Netw       Date:  2014-12-22       Impact factor: 6.303

8.  Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Rathinam Sridhar; Hardy Kornfeld; Thomas B Nutman; Subash Babu
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  Polymorphisms in the interleukin 18 receptor 1 gene and tuberculosis susceptibility among Chinese.

Authors:  Junxian Zhang; Li Zheng; Donglin Zhu; Huiru An; Yourong Yang; Yan Liang; Weiguo Zhao; Wenjun Ding; Xueqiong Wu
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

10.  Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.

Authors:  Ning-Kui Niu; Juan-Juan Yin; Yin-Xue Yang; Zi-Li Wang; Zhi-Wei Zhou; Zhi-Xu He; Xiao-Wu Chen; Xueji Zhang; Wei Duan; Tianxin Yang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.